![No Surprises Act: Rising Costs & Potential Premium Hikes [Analysis]](https://imgproxy.divecdn.com/hbgQM4p6lU4_lkhDZsUhkrVuIzkqY3nInY4koYbLH54/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy05NjkwNjU5ODAuanBn.webp "No Surprises Act: Rising Costs & Potential Premium Hikes [Analysis]")
The No Surprises Act Dispute Resolution Process Faces growing Pains: rising Costs and Private Equity Influence Raise Concerns
The No Surprises Act, designed to protect patients from unexpected medical bills, is facing an unexpected challenge: its independent dispute resolution (IDR) process is becoming increasingly costly and is showing signs of being exploited, potentially driving up healthcare premiums. A recent analysis reveals a system overwhelmed with disputes, dominated by a handful of large provider groups – many backed by private equity – and yielding payment awards significantly higher than initially anticipated. This article delves into the issues plaguing the IDR process, explores the contributing factors, and outlines potential solutions to ensure the Act fulfills its original intent.
A Surge in Disputes Overwhelms the System
Implemented to resolve billing disputes between insurers and out-of-network providers for emergency and certain scheduled services, the IDR process has been inundated since its inception.Initial projections estimated around 500 disputes would be processed monthly. However,the reality has far exceeded expectations. As of May, a staggering backlog of nearly 500,000 disputes exists, demonstrating a system struggling to keep pace with demand. This surge is not simply a matter of volume; it’s a matter of who is filing and how disputes are being resolved.
Private Equity’s Outsized Role Fuels Concerns
The analysis highlights a concerning trend: a disproportionate number of IDR claims originate from a small number of provider organizations, particularly those backed by private equity. Radiology Partners and TeamHealth alone accounted for 43% of all resolved claims in 2023 and 2024. Collectively, the top five provider organizations are responsible for nearly 60% of all claims submitted.
This concentration raises red flags. experts suggest this dominance indicates a strategic approach to leveraging the IDR process for financial gain, rather than a genuine effort to resolve legitimate billing discrepancies. The high success rate of these providers – and the substantial awards they receive – further fuel these concerns.
IDR Awards Exceed Expectations, Threatening Premium Stability
The financial implications of the IDR process are significant. In the fourth quarter of 2024,providers winning disputes received a median payment award exceeding four times the qualifying payment amount (QPA).the QPA represents the in-network rate for a service in a specific geographic area, serving as a benchmark for reasonable reimbursement.
This disparity directly contradicts the original intent of the No Surprises Act. The Congressional Budget Office (CBO) initially predicted modest IDR awards would contribute to lower premiums by encouraging negotiation and downward pressure on pricing. though, researchers at Georgetown University’s Center on Health Insurance Reforms now warn that IDR outcomes are potentially reversing this expectation.
“As dispute volume grows, so will costs,” warn Jack Hoadley and Kennah watts, authors of the recent report.”Over time, future network contract negotiations could reflect the higher amounts awarded through IDR.” This suggests a potential ripple effect, were inflated IDR awards become the new baseline for contract negotiations, ultimately leading to higher healthcare costs for consumers.
A Clash of Perspectives: Providers vs. Insurers
The diverging outcomes of the IDR process have ignited a debate between providers and insurers. Providers argue that the high award amounts demonstrate that insurers’ initial offers, typically based on the QPA, are unfairly low. They contend the IDR process is simply correcting an imbalance and ensuring fair compensation for out-of-network services.
Insurers, however, allege that a select group of “bad actors” are exploiting the IDR process to inflate reimbursement rates and profit from remaining outside of network. This accusation is supported by recent legal action.
Legal Battles and Regulatory Scrutiny
The concerns surrounding the IDR process have spilled over into the courtroom. Elevance Health recently sued two Georgia providers and their billing company, HaloMd, alleging they intentionally flooded the arbitration process with ineligible disputes to maximize profits. This lawsuit is just one in a series of legal challenges filed by both provider associations and insurers, often centered on the factors arbitrators are permitted to consider when determining fair payment amounts.
While providers have generally been successful in these legal battles – leading to revisions in the dispute resolution process and contributing to the current backlog – the constant legal challenges and subsequent pauses and restarts of the IDR portal have created instability and further exacerbated the system’s inefficiencies.
Potential Solutions: Strengthening Oversight and Enhancing clarity
Addressing the challenges facing the IDR process requires a multi-pronged approach. Hoadley and Watts propose several policy levers to prevent escalating costs and ensure the Act’s effectiveness:
*
![Harvard Medical School: 6 Top Investments for Health Systems | [Year]](https://i0.wp.com/hitconsultant.net/wp-content/uploads/2025/12/Harvard-Primary-Care-Investment-Guide.jpg?resize=330%2C220&ssl=1 "Harvard Medical School: 6 Top Investments for Health Systems | [Year]")
